Cargando…

Acyclovir-induced neurotoxicity in an immunocompromised patient

This is a case report of a 75-year-old immunocompromised male who developed encephalopathy while undergoing treatment for disseminated herpes zoster with peripheral nerve involvement. While his initial presentation involved primarily profound lower extremity weakness, he developed progressive confus...

Descripción completa

Detalles Bibliográficos
Autores principales: Marks, Daniel, De La Paz, Andrew, Walston, Bobbi Jo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7425261/
https://www.ncbi.nlm.nih.gov/pubmed/32850129
http://dx.doi.org/10.1177/2050313X20946518
_version_ 1783570463095521280
author Marks, Daniel
De La Paz, Andrew
Walston, Bobbi Jo
author_facet Marks, Daniel
De La Paz, Andrew
Walston, Bobbi Jo
author_sort Marks, Daniel
collection PubMed
description This is a case report of a 75-year-old immunocompromised male who developed encephalopathy while undergoing treatment for disseminated herpes zoster with peripheral nerve involvement. While his initial presentation involved primarily profound lower extremity weakness, he developed progressive confusion to the point of obtundation only after initiation of standard therapy with intravenous acyclovir. The evaluation of his altered mental status was largely unremarkable. It was only after his acyclovir was discontinued that his symptoms resolved and he returned to his baseline mental status. His presentation was most consistent with acyclovir-induced neurotoxicity, which can present in patients with renal impairment and those who are immunocompromised.
format Online
Article
Text
id pubmed-7425261
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-74252612020-08-25 Acyclovir-induced neurotoxicity in an immunocompromised patient Marks, Daniel De La Paz, Andrew Walston, Bobbi Jo SAGE Open Med Case Rep Case Report This is a case report of a 75-year-old immunocompromised male who developed encephalopathy while undergoing treatment for disseminated herpes zoster with peripheral nerve involvement. While his initial presentation involved primarily profound lower extremity weakness, he developed progressive confusion to the point of obtundation only after initiation of standard therapy with intravenous acyclovir. The evaluation of his altered mental status was largely unremarkable. It was only after his acyclovir was discontinued that his symptoms resolved and he returned to his baseline mental status. His presentation was most consistent with acyclovir-induced neurotoxicity, which can present in patients with renal impairment and those who are immunocompromised. SAGE Publications 2020-08-11 /pmc/articles/PMC7425261/ /pubmed/32850129 http://dx.doi.org/10.1177/2050313X20946518 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Case Report
Marks, Daniel
De La Paz, Andrew
Walston, Bobbi Jo
Acyclovir-induced neurotoxicity in an immunocompromised patient
title Acyclovir-induced neurotoxicity in an immunocompromised patient
title_full Acyclovir-induced neurotoxicity in an immunocompromised patient
title_fullStr Acyclovir-induced neurotoxicity in an immunocompromised patient
title_full_unstemmed Acyclovir-induced neurotoxicity in an immunocompromised patient
title_short Acyclovir-induced neurotoxicity in an immunocompromised patient
title_sort acyclovir-induced neurotoxicity in an immunocompromised patient
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7425261/
https://www.ncbi.nlm.nih.gov/pubmed/32850129
http://dx.doi.org/10.1177/2050313X20946518
work_keys_str_mv AT marksdaniel acyclovirinducedneurotoxicityinanimmunocompromisedpatient
AT delapazandrew acyclovirinducedneurotoxicityinanimmunocompromisedpatient
AT walstonbobbijo acyclovirinducedneurotoxicityinanimmunocompromisedpatient